|
業務類別
|
-- |
|
業務概覽
|
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas. |
| 公司地址
| Kungsbroplan 3A, Stockholm, SWE, SE-112 27 |
| 電話號碼
| +46 855529300 |
| 傳真號碼
| +46 855529301 |
| 公司網頁
| https://www.biogaiagroup.com |
| 員工數量
| 242 |
| Mr. Alexander Kotsinas |
Executive Vice President and Chief Financial Officer |
-- |
30/03/2026 |
| Ms. Theresa Agnew |
Chief Executive Officer and President |
-- |
30/03/2026 |
|
|
| Mr. David E. R. Dangoor |
Vice Chairman of the Board |
30/03/2026 |
| Mr. Mauricio Graber |
Chairman of the Board |
30/03/2026 |
| Mr. Anthon Jahreskog |
Independent Director |
30/03/2026 |
| Dr. Barbro Friden |
Independent Director |
30/03/2026 |
| Ms. Vanessa Rothschild |
Independent Director |
30/03/2026 |
| Ms. Benedicte Flambard |
Independent Director |
30/03/2026 |
| Ms. Outi Helena Armstrong |
Independent Director |
30/03/2026 |
|
|
|
|
